american diabetes association pancreatitis history glp-1 receptor agonist Risk Associated with Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Patients in the United States: A Propensity Score-Matched Analysis Does Semaglutide Cause Pancreatitis? Evidence
Description
Cardiovascular-risk coverage under private plans in So Paulo already rose in 2025, and Mexicos ISSSTE is examining similar add-on benefits for 2027

Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects over 100 million Americans

Who should not use Zepbound

They also decreased body weight, potentially contributing to mitigate the direct impact of obesity on CKD

being a consultant to Takeda Pharmaceuticals and Haisco Pharmaceutical Group

doi: 10.2337/db09-1694 60 RakipovskiGRolinBNhrJKleweIFrederiksenKSAugustinRet al
